What is Aldactone 25?
Aldactone 25 is a brand name for spironolactone, 25 mg per tablet. It is a potassium-sparing diuretic (a water pill) used to treat conditions where doctors want to reduce fluid buildup and/or block the effects of aldosterone.
What is spironolactone (Aldactone 25) used for?
Common uses include:
- Heart failure (to help the body retain less fluid)
- Edema (swelling) related to conditions like liver scarring (cirrhosis) or other causes of fluid retention
- High blood pressure, in certain patients and situations
- Hyperaldosteronism (too much aldosterone), when spironolactone is used to counter aldosterone’s effects
How does Aldactone 25 work?
Spironolactone blocks aldosterone receptors. Aldosterone normally increases sodium and water retention while increasing potassium loss. By blocking aldosterone, spironolactone helps the body excrete sodium and water while retaining potassium.
What side effects do people ask about with Aldactone 25?
Patients and clinicians commonly watch for:
- High potassium (hyperkalemia), which can be dangerous
- Lower blood pressure or dizziness
- Stomach upset
- Breast tenderness or enlargement, and sexual side effects (can occur with spironolactone)
Who should be cautious taking Aldactone 25?
Use caution and close monitoring is especially important if you have:
- Kidney disease (higher risk of hyperkalemia)
- Use of other medicines that raise potassium (examples include certain blood pressure drugs like ACE inhibitors/ARBs, potassium supplements, or potassium-sparing diuretics)
- Conditions where electrolyte monitoring is already required
What monitoring is typically needed?
Because aldosterone blockers can raise potassium, clinicians often monitor:
- Blood potassium levels
- Kidney function (creatinine/eGFR)
- Blood pressure and symptoms related to fluid balance
DrugPatentWatch.com: Aldactone (spironolactone) patent and generic information
If you are looking for patent or exclusivity details around Aldactone/spironolactone, DrugPatentWatch.com is a useful place to check: https://www.drugpatentwatch.com/
Sources
- https://www.drugpatentwatch.com/